Free Trial

Bicara Therapeutics (BCAX) Institutional Ownership

Bicara Therapeutics logo
$12.62 -0.29 (-2.25%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$12.65 +0.03 (+0.27%)
As of 01/31/2025 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)

Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$397.07M
Number of
Institutional Sellers
(last 12 months)
0
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BCAX Institutional Buying and Selling by Quarter

Bicara Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/30/2025 Rhumbline Advisers19,008$331K0.0%N/A0.035%
1/24/2025 Spire Wealth Management1,804$31K0.0%N/A0.003%
1/17/2025 SG Americas Securities LLC8,411$147K0.0%N/A0.015%
11/19/2024Barclays PLC10,000$255K0.0%N/A0.018%
11/18/2024Teachers Retirement System of The State of Kentucky14,039$358K0.0%N/A0.026%
11/16/2024Geode Capital Management LLC48,639$1.24M0.0%N/A0.094%
11/15/2024Barclays PLC10,000$255K0.0%N/A0.019%
11/15/2024Jane Street Group LLC12,151$309K0.0%N/A0.023%
11/15/2024Wellington Management Group LLP763,943$19.46M0.0%N/A1.476%
11/15/2024Soros Fund Management LLC20,000$509K0.0%N/A0.039%
11/15/2024Samsara BioCapital LLC35,000$891K0.2%N/A0.068%
11/15/2024RA Capital Management L.P.6,955,993$177.17M2.0%N/A13.439%
11/15/2024Point72 DIFC Ltd55,757$1.42M0.0%N/A0.108%
11/15/2024Point72 Asset Management L.P.371,962$9.47M0.0%N/A0.719%
11/15/2024Maven Securities LTD50,000$1.27M0.0%N/A0.097%
11/15/2024Iron Triangle Partners LP200,000$5.09M0.7%N/A0.386%
11/15/2024Janus Henderson Group PLC1,188,191$30.33M0.0%N/A2.296%
11/15/2024Cinctive Capital Management LP9,001$229K0.0%N/A0.017%
11/15/2024Baker BROS. Advisors LP833,333$21.23M0.2%N/A1.610%
11/15/2024Point72 Asia Singapore Pte. Ltd.18,125$462K0.1%N/A0.035%
11/14/2024Braidwell LP1,657,600$42.22M1.2%N/A3.202%
11/14/2024Vestal Point Capital LP425,000$10.83M0.8%N/A0.821%
11/14/2024Walleye Capital LLC31,780$809K0.0%N/A0.061%
11/13/2024FMR LLC2,273,792$57.91M0.0%N/A4.393%
11/13/2024The Manufacturers Life Insurance Company22,859$582K0.0%N/A0.044%
11/7/2024First Turn Management LLC562,391$14.32M2.3%N/A1.087%
(Data available from 1/1/2016 forward)

BCAX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BCAX shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Braidwell LP ($42.22M), Janus Henderson Group PLC ($30.33M), Baker BROS. Advisors LP ($21.23M), Wellington Management Group LLP ($19.46M), and First Turn Management LLC ($14.32M).Learn more on BCAX's institutional investors.

Which institutional investors have been buying Bicara Therapeutics stock?

Of the 25 institutional investors that purchased Bicara Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), FMR LLC ($2.27M), Braidwell LP ($1.66M), Janus Henderson Group PLC ($1.19M), Baker BROS. Advisors LP ($833.33K), Wellington Management Group LLP ($763.94K), and First Turn Management LLC ($562.39K).

How much institutional buying is happening at Bicara Therapeutics?

Institutional investors have bought a total of 15,598,779 shares in the last 24 months. This purchase volume represents approximately $397.07M in transactions.



This page (NASDAQ:BCAX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners